BridgeBio Pharma
$66.91Change from previous close: +1.69%Absolute change: +$1.11
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $13.08B
- Enterprise value
- $15.74B
- Forward P/E
- 2,435.7
- Price/sales
- 18.3
- EV/EBITDA
- -33.3
- EV/revenue
- 22.1
Profitability and growth
- Gross margin
- 94.4%
- Operating margin
- -43.9%
- Net margin
- -97.0%
- ROA
- -26.0%
- Revenue growth (year over year)
- 120.4%
Financial health
- Total cash
- $720.16M
- Total debt
- $3.37B
- Current ratio
- 1.23
- Quick ratio
- 1.09
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $109.10
- Median price target
- $110.00
- High price target
- $157.00
- Low price target
- $80.00
- Analysts with a price target
- 21
- Consensus
- Strong buy
- Forward EPS
- $0.03
- EPS estimate, current year
- -$2.58
Shares and trading
- Beta
- 0.97
- Average volume
- 2.74M
- Shares outstanding
- 195.49M
- Float
- 167.19M
- Institutional ownership
- 99.5%
- Insider ownership
- 3.9%
- Short interest (% of float)
- 12.3%
- Short ratio (days)
- 10.6